Wednesday, May 6, 2026
Newsletter About
Business & Finance

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount 

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

This article was originally published by CNBC Top News and is republished here under license.

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

More in Business & Finance

View All →

Leave a Reply

Discover more from The Meridian Review

Subscribe now to keep reading and get access to the full archive.

Continue reading